GlassScriptPhysician profile
Collins N Okolie
NPI 1235331224
$1,382.80
in general payments reported to CMS, 2019-2025
17 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.07 · 2022: $156 · 2023: $190 · 2024: $580 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.97 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $333.08 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $154.72 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $147.61 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $127.74 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $107.49 | 2022-2025 | |
| Abbvie INC. | $98.85 | 2023-2025 | |
| Astellas Pharma US INC | $71.15 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $61.14 | 2022-2025 | |
| Glaxosmithkline, LLC. | $52.04 | 2022-2025 | Shingrix, Arexvy |
| Amgen INC. | $45.24 | 2019-2025 | Repatha, Otezla, Otezla |
| Merck Sharp & Dohme LLC | $45.17 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.08 | 2022-2024 | Jardiance |
| Dexcom, INC. | $30.02 | 2024 | Dexcom G6 Transmitter |
| Intuitive Surgical, INC. | $28.29 | 2024 | |
| Trice Medical, INC. | $17.84 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.93 | 2023 | Spravato |
| Exact Sciences Corporation | $14.41 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collins Okolie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.